FDA-Approved vs Supplement Potassium Iodide: A Critical Distinction

This page explores the regulatory and practical differences between FDA-approved potassium iodide drugs and dietary supplements containing KI. For a direct product comparison, see our comparison page.

The NDA/ANDA Drug Approval Pathway

FDA-approved KI products like iOSAT and ThyroSafe went through the formal drug approval process. This requires submission of clinical data proving safety, efficacy, bioavailability, potency, purity, and long-term stability. Manufacturing facilities undergo ongoing FDA inspection.

The DSHEA Supplement Framework

Dietary supplements operate under the 1994 Dietary Supplement Health and Education Act (DSHEA). Under DSHEA, supplements do not require pre-market approval. The FDA must prove a supplement is unsafe before it can be removed — the burden of proof is reversed compared to drugs.

The Dose Gap Problem

Most daily thyroid support supplements contain 225 mcg of iodine. The emergency KI dose is 130 mg = 130,000 mcg. That means a daily supplement provides 0.17% of the emergency dose. You would need approximately 578 capsules of a standard thyroid supplement to equal one emergency KI tablet. The CDC explicitly warns against using daily supplements as emergency KI substitutes.

How to Verify FDA Status

1. Search for the product's NDC number on DailyMed
2. If it appears with NDA or ANDA approval type, it's FDA-approved
3. If it doesn't appear on DailyMed, it's a supplement

KIO₃ Warning

Potassium iodate (KIO₃) is sometimes sold as an alternative. The FDA has stated KIO₃ has "serious safety and effectiveness concerns" and it is NOT approved for emergency use. See our KI vs KIO₃ guide.